Abstract
The present study illustrates the potential use of aripiprazole as part of the management of post-traumatic stress disorder (PTSD) in returning Global War on Terrorism (GWOT) veterans. Five consecutive cases of GWOT combat-related PTSD, managed in part with the atypical antipsychotic medication aripiprazole, are presented and discussed. In four of the five cases reported, the medication was well-tolerated and was effective in the management of sleep disturbances, such as nightmares and agitated behaviours during sleep, and was also helpful in the management of hyper-arousal. In one case, the veteran experienced a paradoxical excitation response to the medication. Aripiprazole, in conjunction with other medications or psychotherapeutic interventions, should be studied further for its potential role in the management of PTSD.
References
Jul 19, 2001·International Clinical Psychopharmacology·M I ButterfieldJ R Davidson
Oct 3, 2002·The American Journal of Psychiatry·Murray B SteinJeffrey L Matloff
Oct 5, 2002·The Journal of Clinical Psychiatry·Cynthia J KornegayHershel Jick
May 20, 2003·Acta Psychiatrica Scandinavica·M JakovljevićA Mihaljević-Peles
Jan 30, 2004·Diabetes Care·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
May 25, 2004·Primary Care Companion to the Journal of Clinical Psychiatry·James H. States, Clarke D. St Dennis
Jul 9, 2005·Military Medicine·Christine Maura DalyColin Daniels
Jul 26, 2005·Journal of Psychiatric Practice·Franca CentorrinoRoss J Baldessarini
Citations
May 15, 2009·Journal of Clinical Psychopharmacology·Hua JinDilip V Jeste
Jan 23, 2014·Experimental Brain Research·Gaétane DeliensPhilippe Peigneux
Dec 14, 2011·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Mark B DetweilerKye Y Kim
May 19, 2011·BMC Psychiatry·J Don RichardsonDiane McIntosh
Jul 8, 2011·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Bevanne Bean-MayberryPaul G Shekelle
Mar 20, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Chiung-Chi YehVincent C H Chen
Jan 15, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·William BergerIvan Figueira
May 2, 2008·Pharmacotherapy·Lisa J Miller
Jan 21, 2015·Neurobiology of Learning and Memory·Nina LandmannChristoph Nissen
Dec 22, 2016·Journal of Clinical Medicine·Mark B DetweilerBrian W Lutgens
Jan 15, 2009·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Marcelo Feijo MelloJose Paulo Fiks
Aug 14, 2010·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Elliott Kyung Lee, Alan B Douglass
Sep 13, 2007·The Annals of Pharmacotherapy·Prasad R PadalaSubhash C Bhatia
Oct 24, 2017·Clinical Neuropharmacology·Sara R BritnellBruce P Capehart
Nov 9, 2010·Journal of Clinical Psychopharmacology·Nina KhachiyantsMark B Detweiler
Dec 20, 2018·British Journal for the History of Science·Martin Mahony
Nov 10, 2013·Clinical Neuropharmacology·Hee Ryung WangWon-Myong Bahk
Jun 2, 2020·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Motohiro OzoneMasahiro Shigeta
Dec 21, 2019·The Mental Health Clinician·Megan Ehret
Dec 25, 2007·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·William BergerMauro Vitor Mendlowicz
Jul 28, 2019·International Journal of Molecular Sciences·Yasushi Yabuki, Kohji Fukunaga
Oct 12, 2018·Current Psychiatry Reports·Scott H WaltmanBret A Moore
Nov 24, 2020·Frontiers in Neurology·Alain Nicolas, Perrine M Ruby
Nov 24, 2020·Child and Adolescent Psychiatric Clinics of North America·Veronica FellmanSuchet Rao